Mar 13, 2018 11:30 am UTC| Business
NEW YORK, NY, March 13, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Methanex...
Pacific Biosciences Announces Issuance of U.S. Patent for Concatemer Sequencing
Mar 13, 2018 11:30 am UTC| Business
MENLO PARK, Calif., March 13, 2018 -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark Office (“USPTO”) has...
Mar 13, 2018 11:30 am UTC| Business
RICHMOND, Va., March 13, 2018 -- Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the fourth quarter of 2017 of $52.8 million. This represents an increase of $19.8 million or 60% when compared to net...
Mar 13, 2018 11:30 am UTC| Business
Leadership team to leverage best-in-class operational excellence, disciplined project execution and track record of strong cost management to unlock near- and long-term value ...
Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones
Mar 13, 2018 11:30 am UTC| Business
First Tazemetostat NDA Submission for Epithelioid Sarcoma Targeted for Fourth Quarter of 2018; Second Tazemetostat NDA Submission for Follicular Lymphoma Targeted for 2019 Multiple Phase 2 Study Data Readouts Planned in...
Mar 13, 2018 11:30 am UTC| Business
NEW YORK, March 13, 2018 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that the...
OpGen Announces Collaborator in Verification Study for Acuitas® Test
Mar 13, 2018 11:30 am UTC| Business
GAITHERSBURG, Md., March 13, 2018 -- OpGen, Inc. (NASDAQ:OPGN) announced today that it is collaborating with Beth Israel Deaconess Medical Center (BIDMC) in Boston on a verification study for OpGen’s Acuitas® AMR Gene...